In its Series C fundraising round, Zeno Health, a marketplace for high-quality and reasonably priced generic medications, secures USD 25 million.
STIC Investments has spearheaded the round. Another big investor in the round was Lightbox, a previous investor in Zeno Health.
Read also – [Funding alert] Fintech Platform Mswipe Secures $20 Mn Growth Capital Led by Alpha Wave Global
Siddharth Gadia, CEO and Co-founder of Zeno Health, expressed gratitude for the support, stating, “We are thrilled to welcome STIC as a key partner in our journey. Their investment, coupled with the continued commitment from Lightbox, signifies a resounding endorsement of our mission to make quality healthcare affordable to all.”
Genuine, premium generic and branded medications are available at Zeno Health with assured savings. In addition to non-prescription products for general health, well-being, and personal care, Zeno Health offers access to prescription medications for chronic and recurrent disorders.
“Zeno Health has demonstrated a remarkable commitment to reshaping the healthcare landscape in India. Their vision aligns with our values, and we look forward to contributing to their journey towards making quality healthcare accessible across India,” said Derrick (Kihyun) Yun – Managing Director, STIC.
Read also – [Funding alert] Shadowfax Raises USD 100 Mn Series E Round Funding Led by TPG NewQuest
About Zeno Health
Founded in 2017 by IIT Bombay alumni- Siddharth Gadia and Girish Agarwal, Zeno Health is a Generic Medicine-focused pharmacy. Zeno Health provides access to prescription medicines for chronic and recurring diseases as well as non-prescription goods for general health, well-being and personal care.
